Our observation about FOXO3 protein overexpression and activation in HCC samples nevertheless brought us a question, whether hepatic activation of FOXO3 in patients sufficiently supports hepatocellular carcinogenesis, or FOXO3 activation is just a consequence and secondary-effect during tumor development. Here, FOXO3 is linked to neoplasm.